ZoladexOrdering.com

Welcome to ZOLADEX Ordering - We are pleased to offer health care professionals the ability to order ZOLADEX online along with educational and support materials.

At ZOLADEXordering.com, you can find the following services:

Order ZOLADEX 3.6 mg 1-month Depot and 10.8 mg 3-month Depot
View video on administration of ZOLADEX
Download materials for your patients and health care team
Order printed materials for your patients and health care team

Logon to ZOLADEX
Ordering

Prescribing Information

Print This Page

Send to a Colleague

Change Text Size - A A A

Don't have time for another phone call? Online ordering is 3 clicks away. Click here for the shipping schedule.

Prostate cancer information for patients and health care professionals. PROSTATEinfo.com

Site Map | Contact Us | Privacy Statement | Legal Information

ZOLADEX is indicated in the palliative treatment of advanced carcinoma of the prostate.

The most common adverse events (incidence > 5% in clinical trials) were: for ZOLADEX 3.6 mg depot — hot flashes (62%), sexual dysfunction (21%), decreased erections (18%), lower urinary tract symptoms (13%), lethargy (8%), pain (worsened in the first 30 days) (8%), edema (7%), upper respiratory infection (7%), rash (6%), and sweating (6%). For ZOLADEX 10.8 mg depot — hot flashes (64%), pain (general) (14%), gynecomastia (8%), pelvic pain (6%), and bone pain (6%).

ZOLADEX is also indicated for use in combination with flutamide for the management of locally advanced Stage T2b-T4 (Stage B2-C) carcinoma of the prostate. Treatment with the combination should start 8 weeks prior to initiating radiation therapy and continue during radiation therapy.

Additional adverse event data were collected for the combination therapy with radiation group during both the hormonal treatment and hormonal treatment plus radiation phases of this study. Adverse experiences (incidence > 5%) in both phases of this study were hot flashes (46%), diarrhea (40%), nausea (9%), and skin rash (8%).

ZOLADEX^® (goserelin acetate implant) 3.6 mg 1-month Depot Full Prescribing Information
ZOLADEX^® (goserelin acetate implant) 10.8 mg 3-month Depot Full Prescribing Information

ZOLADEX is a registered trademark of the AstraZeneca group of companies.

This information is intended for US health care professionals only.

US Corporate Site